Form 4 Tracker
RA CAPITAL MANAGEMENT, L.P.

10% Owner; Director; Director, 10% Owner · 48 filings · Latest: Jun 29, 2026

Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Hemab Therapeutics Holdings, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VOR
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerApr 10, 2026
Sale
$15.75828$13.0K3,935,608
VOR
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerApr 9, 2026
Sale
$16.59135,201$2.2M3,936,436
VOR
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerApr 8, 2026
Sale
$16.48484,104$8.0M4,071,637
VOR
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerApr 6, 2026
Sale
$16.59589,257$9.8M4,555,741
VOR
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerApr 2, 2026
Sale
$18.23260,000$4.7M5,144,998
MLYS
RA CAPITAL MANAGEMENT, L.P.DirectorMar 30, 2026
Purchase
$24.1658,300$1.4M5,825,521
MLYS
RA CAPITAL MANAGEMENT, L.P.DirectorMar 27, 2026
Purchase
$23.67310,700$7.4M5,767,221
WVE
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerMar 30, 2026
Purchase
$6.50971,091$6.3M26,975,505
WVE
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerMar 27, 2026
Purchase
$6.432,495,623$16.0M26,004,414
WVE
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerMar 26, 2026
Purchase
$6.085,305,782$32.3M23,508,791
BCAX
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerFeb 26, 2026
Purchase
$16.00300,000$4.8M4,603,418
SGP
RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerFeb 9, 2026
Purchase
$16.003,690,000$59.0M2,054,678

← Previous

Page 3 of 3